Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant α-Interferon Treatment After Resection of Hepatocellular Carcinoma in HCV-Related Cirrhosis: a Randomized Trial on Prevention of Cancer Recurrence

NCT00273247 is registered in ClinicalTrials.gov with National Cancer Institute, Milan as lead sponsor.

NCT NCT00273247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00273247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant α-Interferon Treatment After Resection of Hepatocellular Carcinoma in HCV-Related Cirrhosis: a Randomized Trial on Prevention of Cancer Recurrence
Lead sponsor
National Cancer Institute, Milan
Phase
Phase 3
Overall status
Completed
Start date
June 30, 1998
Completion date
September 30, 2005
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic resection, hepatitis c virus infection, hepatocellular carcinoma, interferon treatment, liver cirrhosis